Releases › ICD-10-PCS FY2026
ICD-10-PCS FY2026
Effective 2025-10-01 to 2026-03-31. 79,115 codes in the release.
160added
0revised
27removed
Codes added 160
| Code | Description |
|---|---|
| 00H033J | Insertion of Infusion Device into Brain, Temporary, Percutaneous Approach |
| 00P207Z | Removal of Autologous Tissue Substitute from Dura Mater, Open Approach |
| 00P20JZ | Removal of Synthetic Substitute from Dura Mater, Open Approach |
| 00P20KZ | Removal of Nonautologous Tissue Substitute from Dura Mater, Open Approach |
| 00PT07Z | Removal of Autologous Tissue Substitute from Spinal Meninges, Open Approach |
| 00PT0JZ | Removal of Synthetic Substitute from Spinal Meninges, Open Approach |
| 00PT0KZ | Removal of Nonautologous Tissue Substitute from Spinal Meninges, Open Approach |
| 00W207Z | Revision of Autologous Tissue Substitute in Dura Mater, Open Approach |
| 00W20JZ | Revision of Synthetic Substitute in Dura Mater, Open Approach |
| 00W20KZ | Revision of Nonautologous Tissue Substitute in Dura Mater, Open Approach |
| 00WT07Z | Revision of Autologous Tissue Substitute in Spinal Meninges, Open Approach |
| 00WT0JZ | Revision of Synthetic Substitute in Spinal Meninges, Open Approach |
| 00WT0KZ | Revision of Nonautologous Tissue Substitute in Spinal Meninges, Open Approach |
| 02UW3LZ | Supplement Thoracic Aorta, Descending with Intraluminal Device, Endovascular Anchors, Percutaneous Approach |
| 031209Y | Bypass Innominate Artery to Upper Artery with Autologous Venous Tissue, Open Approach |
| 03120AY | Bypass Innominate Artery to Upper Artery with Autologous Arterial Tissue, Open Approach |
| 03120JY | Bypass Innominate Artery to Upper Artery with Synthetic Substitute, Open Approach |
| 03120KY | Bypass Innominate Artery to Upper Artery with Nonautologous Tissue Substitute, Open Approach |
| 03120ZY | Bypass Innominate Artery to Upper Artery, Open Approach |
| 04U03LZ | Supplement Abdominal Aorta with Intraluminal Device, Endovascular Anchors, Percutaneous Approach |
| 09X | Ear, Nose, Sinus, Transfer |
| 09XK0Z1 | Transfer Nasal Mucosa and Soft Tissue to Frontal Bone, Open Approach |
| 09XK0Z2 | Transfer Nasal Mucosa and Soft Tissue to Ethmoid Bone, Open Approach |
| 09XK0Z3 | Transfer Nasal Mucosa and Soft Tissue to Sphenoid Bone, Open Approach |
| 09XK0Z4 | Transfer Nasal Mucosa and Soft Tissue to Occipital Bone, Open Approach |
| 09XL0Z1 | Transfer Nasal Turbinate to Frontal Bone, Open Approach |
| 09XL0Z2 | Transfer Nasal Turbinate to Ethmoid Bone, Open Approach |
| 09XL0Z3 | Transfer Nasal Turbinate to Sphenoid Bone, Open Approach |
| 09XL0Z4 | Transfer Nasal Turbinate to Occipital Bone, Open Approach |
| 09XM0Z1 | Transfer Nasal Septum to Frontal Bone, Open Approach |
| 09XM0Z2 | Transfer Nasal Septum to Ethmoid Bone, Open Approach |
| 09XM0Z3 | Transfer Nasal Septum to Sphenoid Bone, Open Approach |
| 09XM0Z4 | Transfer Nasal Septum to Occipital Bone, Open Approach |
| 0C1 | Mouth and Throat, Bypass |
| 0C1S0E4 | Bypass Larynx to Cutaneous with Endotracheal Airway, Open Approach |
| 0C1S0F4 | Bypass Larynx to Cutaneous with Tracheostomy Device, Open Approach |
| 0C1S0Z4 | Bypass Larynx to Cutaneous, Open Approach |
| 0C1S3E4 | Bypass Larynx to Cutaneous with Endotracheal Airway, Percutaneous Approach |
| 0C1S3F4 | Bypass Larynx to Cutaneous with Tracheostomy Device, Percutaneous Approach |
| 0C1S3Z4 | Bypass Larynx to Cutaneous, Percutaneous Approach |
| 0F198D3 | Bypass Common Bile Duct to Duodenum with Intraluminal Device, Via Natural or Artificial Opening Endoscopic |
| 0F198Z3 | Bypass Common Bile Duct to Duodenum, Via Natural or Artificial Opening Endoscopic |
| 0RRJ008 | Replacement of Right Shoulder Joint with Reverse Ball and Socket Synthetic Substitute, Subscapularis-sparing Technique, Open Approach |
| 0RRJ0J8 | Replacement of Right Shoulder Joint with Synthetic Substitute, Subscapularis-sparing Technique, Open Approach |
| 0RRK008 | Replacement of Left Shoulder Joint with Reverse Ball and Socket Synthetic Substitute, Subscapularis-sparing Technique, Open Approach |
| 0RRK0J8 | Replacement of Left Shoulder Joint with Synthetic Substitute, Subscapularis-sparing Technique, Open Approach |
| 0SRC07D | Replacement of Right Knee Joint with Autologous Tissue Substitute, Medial Meniscus, Open Approach |
| 0SRC07E | Replacement of Right Knee Joint with Autologous Tissue Substitute, Lateral Meniscus, Open Approach |
| 0SRC0KD | Replacement of Right Knee Joint with Nonautologous Tissue Substitute, Medial Meniscus, Open Approach |
| 0SRC0KE | Replacement of Right Knee Joint with Nonautologous Tissue Substitute, Lateral Meniscus, Open Approach |
| 0SRD07D | Replacement of Left Knee Joint with Autologous Tissue Substitute, Medial Meniscus, Open Approach |
| 0SRD07E | Replacement of Left Knee Joint with Autologous Tissue Substitute, Lateral Meniscus, Open Approach |
| 0SRD0KD | Replacement of Left Knee Joint with Nonautologous Tissue Substitute, Medial Meniscus, Open Approach |
| 0SRD0KE | Replacement of Left Knee Joint with Nonautologous Tissue Substitute, Lateral Meniscus, Open Approach |
| 5A05A6M | Intraoperative Cerebral Embolic Filtration, Single Capture Filter |
| 5A05A6N | Intraoperative Cerebral Embolic Filtration, Dual Capture Filter |
| 5A05A6P | Intraoperative Cerebral Embolic Filtration, Single Deflection Filter |
| 5A05A6Q | Intraoperative Cerebral Embolic Filtration, Extracorporeal Flow Reversal Circuit |
| 6A4T00A | Hypothermia of Urinary System using Donor Organ Protective Thermal Insulation, Single, Intraoperative |
| 8E0ZXGP | External Confocal Microscopy, Intraoperative Specimen Analysis |
| F08D5AZ | Wound Management Treatment of Integumentary System - Head and Neck using Negative Pressure Therapy |
| F08F5AZ | Wound Management Treatment of Integumentary System - Upper Back / Upper Extremity using Negative Pressure Therapy |
| F08G5AZ | Wound Management Treatment of Integumentary System - Lower Back / Lower Extremity using Negative Pressure Therapy |
| F08H5AZ | Wound Management Treatment of Integumentary System - Whole Body using Negative Pressure Therapy |
| F08J5AZ | Wound Management Treatment of Musculoskeletal System - Head and Neck using Negative Pressure Therapy |
| F08K5AZ | Wound Management Treatment of Musculoskeletal System - Upper Back / Upper Extremity using Negative Pressure Therapy |
| F08L5AZ | Wound Management Treatment of Musculoskeletal System - Lower Back / Lower Extremity using Negative Pressure Therapy |
| F08M5AZ | Wound Management Treatment of Musculoskeletal System - Whole Body using Negative Pressure Therapy |
| X05233B | Destruction of Thoracic Sympathetic Nerve, Cardiac Plexus using Radiofrequency Ablation, Percutaneous Approach, New Technology Group 11 |
| X053X4B | Destruction of Brain using Focused Ultrasound Therapy, External Approach, New Technology Group 11 |
| X27339B | Dilation of Right Pulmonary Artery with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27439B | Dilation of Left Pulmonary Artery with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27535B | Dilation of Right Subclavian Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27635B | Dilation of Left Subclavian Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27735B | Dilation of Right Axillary Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27835B | Dilation of Left Axillary Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27935B | Dilation of Right Brachial Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27A35B | Dilation of Left Brachial Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27B35B | Dilation of Right Basilic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27C35B | Dilation of Left Basilic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27D35B | Dilation of Right Cephalic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27E35B | Dilation of Left Cephalic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27W39B | Dilation of Thoracic Aorta, Descending with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X27X39B | Dilation of Thoracic Aorta, Ascending/Arch with Expandable Intraluminal Device, Percutaneous Approach, New Technology Group 11 |
| X28F3WB | Division of Aortic Valve using Leaflet Laceration, Radiofrequency Energy, Percutaneous Approach, New Technology Group 11 |
| X2AH34B | Right Common Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11 |
| X2AJ34B | Left Common Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11 |
| X2AK34B | Right Internal Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11 |
| X2AL34B | Left Internal Carotid Artery Cerebral Embolic Filtration, Single Integrated Distal Filter, Percutaneous Approach, New Technology Group 11 |
| X2H03BB | Insertion of Volume Sensor Management Device into Inferior Vena Cava, Percutaneous Approach, New Technology Group 11 |
| X2H13XB | Insertion of Temporary Phrenic Nerve/Diaphragm Stimulation Electrodes into Superior Vena Cava, Percutaneous Approach, New Technology Group 11 |
| X2HN37B | Insertion of Endocardiac Pacing Electrode into Left Ventricle, Percutaneous Approach, New Technology Group 11 |
| X2HP38B | Insertion of Temporary Intraluminal Device into Right Anterior Tibial Artery, Percutaneous Approach, New Technology Group 11 |
| X2HQ38B | Insertion of Temporary Intraluminal Device into Left Anterior Tibial Artery, Percutaneous Approach, New Technology Group 11 |
| X2HR38B | Insertion of Temporary Intraluminal Device into Right Posterior Tibial Artery, Percutaneous Approach, New Technology Group 11 |
| X2HS38B | Insertion of Temporary Intraluminal Device into Left Posterior Tibial Artery, Percutaneous Approach, New Technology Group 11 |
| X2HT38B | Insertion of Temporary Intraluminal Device into Right Peroneal Artery, Percutaneous Approach, New Technology Group 11 |
| X2HU38B | Insertion of Temporary Intraluminal Device into Left Peroneal Artery, Percutaneous Approach, New Technology Group 11 |
| X2VY06B | Restriction of Thoracic Aortic Arch and Descending Thoracic Aorta using Uncovered Intraluminal Device with Support Cuff, Open Approach, New Technology Group 11 |
| XDJ | New Technology, Gastrointestinal System, Inspection |
| XDJ07LB | Inspection of Upper Intestinal Tract using Ingestible Capsule with Light Absorption Sensor, Via Natural or Artificial Opening, New Technology Group 11 |
| XHH | New Technology, Skin, Subcutaneous Tissue, Fascia and Breast, Insertion |
| XHH80HB | Insertion of Ultrasound Transmitter and Battery for Endocardiac Pacing Electrode into Chest Subcutaneous Tissue and Fascia, Open Approach, New Technology Group 11 |
| XNH60HB | Insertion of Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device into Right Pelvic Bone, Open Approach, New Technology Group 11 |
| XNH63HB | Insertion of Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device into Right Pelvic Bone, Percutaneous Approach, New Technology Group 11 |
| XNH70HB | Insertion of Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device into Left Pelvic Bone, Open Approach, New Technology Group 11 |
| XNH73HB | Insertion of Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device into Left Pelvic Bone, Percutaneous Approach, New Technology Group 11 |
| XNSN0HB | Reposition Right Pelvic Bone with Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Open Approach, New Technology Group 11 |
| XNSN3HB | Reposition Right Pelvic Bone with Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Percutaneous Approach, New Technology Group 11 |
| XNSP0HB | Reposition Left Pelvic Bone with Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Open Approach, New Technology Group 11 |
| XNSP3HB | Reposition Left Pelvic Bone with Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Percutaneous Approach, New Technology Group 11 |
| XRG10RB | Fusion of Cervical Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 11 |
| XRG13RB | Fusion of Cervical Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 11 |
| XRG14RB | Fusion of Cervical Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 11 |
| XRG20RB | Fusion of 2 or more Cervical Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 11 |
| XRG23RB | Fusion of 2 or more Cervical Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 11 |
| XRG24RB | Fusion of 2 or more Cervical Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 11 |
| XRG40RB | Fusion of Cervicothoracic Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 11 |
| XRG43RB | Fusion of Cervicothoracic Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 11 |
| XRG44RB | Fusion of Cervicothoracic Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 11 |
| XRGE0HB | Fusion of Right Sacroiliac Joint using Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Open Approach, New Technology Group 11 |
| XRGE3HB | Fusion of Right Sacroiliac Joint using Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Percutaneous Approach, New Technology Group 11 |
| XRGF0HB | Fusion of Left Sacroiliac Joint using Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Open Approach, New Technology Group 11 |
| XRGF3HB | Fusion of Left Sacroiliac Joint using Bone-Density-Specific Thread and Porosity Pattern Internal Fixation Device, Percutaneous Approach, New Technology Group 11 |
| XRH10GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervical Vertebral Joint, Open Approach, New Technology Group 11 |
| XRH13GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervical Vertebral Joint, Percutaneous Approach, New Technology Group 11 |
| XRH14GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervical Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 11 |
| XRH20GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Open Approach, New Technology Group 11 |
| XRH23GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Percutaneous Approach, New Technology Group 11 |
| XRH24GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 11 |
| XRH40GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Open Approach, New Technology Group 11 |
| XRH43GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Percutaneous Approach, New Technology Group 11 |
| XRH44GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 11 |
| XRH60GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Thoracic Vertebral Joint, Open Approach, New Technology Group 11 |
| XRH63GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Approach, New Technology Group 11 |
| XRH64GB | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 11 |
| XW013TB | Introduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 11 |
| XW033FB | Introduction of Valoctocogene Roxaparvovec-rvox into Peripheral Vein, Percutaneous Approach, New Technology Group 11 |
| XW033PB | Introduction of Aztreonam-avibactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 11 |
| XW033QB | Introduction of Iloprost into Peripheral Vein, Percutaneous Approach, New Technology Group 11 |
| XW033RB | Introduction of Letetresgene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 11 |
| XW033WB | Introduction of Fosfomycin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 11 |
| XW043FB | Introduction of Valoctocogene Roxaparvovec-rvox into Central Vein, Percutaneous Approach, New Technology Group 11 |
| XW043PB | Introduction of Aztreonam-avibactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 11 |
| XW043QB | Introduction of Iloprost into Central Vein, Percutaneous Approach, New Technology Group 11 |
| XW043RB | Introduction of Letetresgene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 11 |
| XW043WB | Introduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 11 |
| XW0DXVB | Introduction of Xanomeline and Trospium Chloride into Mouth and Pharynx, External Approach, New Technology Group 11 |
| XW0U0XB | Introduction of Peptide Enhanced Bone Void Filler into Joints, Open Approach, New Technology Group 11 |
| XW0U3XB | Introduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Approach, New Technology Group 11 |
| XW0U4XB | Introduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Endoscopic Approach, New Technology Group 11 |
| XW133SB | Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11 |
| XW133YB | Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11 |
| XW143SB | Transfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11 |
| XW143YB | Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New Technology Group 11 |
| XX2KXDB | Monitoring of Interstitial Glucose, Wearable Sensor, External Approach, New Technology Group 11 |
| XXA539B | Circulatory Filtration, Ticagrelor, Percutaneous Approach, New Technology Group 11 |
| XXE5XBB | Measurement of Infection and Immune Response, Gene Expression Testing System, New Technology Group 11 |
| XXEZXAB | Measurement of Macronutrient Content, Computer-aided Assessment for Nutrition Management, New Technology Group 11 |
| XXEZXCB | Measurement of Infection, Computer-aided Triage and Notification, New Technology Group 11 |
Codes removed 27
| Code | Description |
|---|---|
| X2A5312 | Cerebral Embolic Filtration, Dual Filter in Innominate Artery and Left Common Carotid Artery, Percutaneous Approach, New Technology Group 2 |
| X2A6325 | Cerebral Embolic Filtration, Single Deflection Filter in Aortic Arch, Percutaneous Approach, New Technology Group 5 |
| X2AH336 | Cerebral Embolic Filtration, Extracorporeal Flow Reversal Circuit from Right Common Carotid Artery, Percutaneous Approach, New Technology Group 6 |
| X2AJ336 | Cerebral Embolic Filtration, Extracorporeal Flow Reversal Circuit from Left Common Carotid Artery, Percutaneous Approach, New Technology Group 6 |
| XW03306 | Introduction of Brexanolone into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
| XW03326 | Introduction of Nerinitide into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
| XW03336 | Introduction of Durvalumab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
| XW03366 | Introduction of Lefamulin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
| XW033A6 | Introduction of Cefiderocol Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
| XW033B6 | Introduction of Omadacycline Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
| XW033C6 | Introduction of Eculizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
| XW033D6 | Introduction of Atezolizumab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
| XW033E6 | Introduction of Etesevimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
| XW033F6 | Introduction of Bamlanivimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
| XW04306 | Introduction of Brexanolone into Central Vein, Percutaneous Approach, New Technology Group 6 |
| XW04326 | Introduction of Nerinitide into Central Vein, Percutaneous Approach, New Technology Group 6 |
| XW04336 | Introduction of Durvalumab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 6 |
| XW04366 | Introduction of Lefamulin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6 |
| XW043A6 | Introduction of Cefiderocol Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6 |
| XW043B6 | Introduction of Omadacycline Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6 |
| XW043C6 | Introduction of Eculizumab into Central Vein, Percutaneous Approach, New Technology Group 6 |
| XW043D6 | Introduction of Atezolizumab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 6 |
| XW043E6 | Introduction of Etesevimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6 |
| XW043F6 | Introduction of Bamlanivimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6 |
| XW0DX66 | Introduction of Lefamulin Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 6 |
| XXE5XN6 | Measurement of Infection, Positive Blood Culture Fluorescence Hybridization for Organism Identification, Concentration and Susceptibility, New Technology Group 6 |
| XXEBXQ6 | Measurement of Infection, Lower Respiratory Fluid Nucleic Acid-base Microbial Detection, New Technology Group 6 |